Ostro Named to Inc.’s 2025 Best in Business List for Best AI Implementation

The annual list recognizes the industry-leading companies that are the best at what they do

NEW YORK--(BUSINESS WIRE)--Ostro, the leader in agentic AI omnichannel engagement platform for life sciences, is proud to announce its inclusion on the Inc. Best in Business list in the Best AI Implementation category. Inc.’s annual Best in Business Awards celebrate the exceptional achievements and contributions of companies that have made a profound impact on their industries.

The recognition honors companies that, through exceptional execution, have achieved significant milestones and core business wins, like customer expansion, key product launches, increased market share, and industry-defining accomplishments. Companies from a wide range of industries – such as technology, health care, finance, and retail – have been recognized for their success and their positive influence on the business world.

The full list can be found on Inc.com and in the upcoming winter print edition of Inc. magazine.

“Each Best in Business honoree achieved a breakthrough moment this year. Some unveiled groundbreaking innovations while others launched savvy marketing campaigns or strategically implemented AI in their companies,” says Bonny Ghosh, editorial director at Inc. “No matter what their business win looked like, their projects and initiatives had a sizable impact on their company and even on their industry at large, making them worthy of this honor.”

Inc.’s Best in Business Awards are open to companies of all sizes and types, in all industries and locations. Public, private, nonprofit, subsidiary, U.S.-based, and international companies are all encouraged to apply. Inc. editors and reporters hand-review every application and select Best in Business honorees that, in each of the award categories, have had an outstanding influence on their communities, their industries, the environment, or society as a whole.

“Our achievements this year reflect the relentless focus, innovation, and excellence of our team and partners,” said Chase Feiger, CEO and Co-Founder of Ostro. “Launching Attruby with BridgeBio allowed us to prove what personalized, agentic-AI can actually do in a real-world patient journey. The impact speaks for itself as patients found answers faster, health care providers stayed informed, and both groups took meaningful action. The industry is headed toward higher-quality engagement, less friction, and smarter use of technology to support better real-world health decisions. Together with our partners, we’re raising the bar for what digital support in life sciences should look like.”

This year, Ostro expanded its footprint in life sciences by powering the launch of Attruby (acoramidis) with BridgeBio and embedding its AI-driven patient engagement technology into the whole treatment ecosystem. The integration brought natural-language search, personalized content, and guided patient pathways directly into the Attruby website, eliminating the jargon-heavy, maze-like experiences typical of pharmaceutical sites. Over the past 12 months, Ostro’s platform has helped patients understand ATTR-CM symptoms, treatment options, and affordability programs while supporting HCPs with easier access to drug information. In parallel, Ostro’s broader business saw significant growth, including a 460 percent expansion within nine months at a top-10 pharmaceutical company and nearly 300 percent growth within a top-50 company, underscoring the accelerating demand for agentic-AI solutions across the industry.

For more information or to see the complete list, please visit inc.com/best-in-business.

About Ostro Health

Ostro is the leader in agentic AI omnichannel engagement platform for life sciences, trusted by a majority of the top 20 pharmaceutical companies. As a pioneer in life sciences commercialization, Ostro has redefined what’s possible for pharmaceutical brands seeking to engage providers and patients across all therapeutic areas. The company’s AI agents orchestrate millions of personalized, compliant interactions across web, email, SMS, and emerging channels—creating a unified intelligence layer that drives measurable behavior change and improved outcomes. Learn more at ostrohealth.com.

About Inc.

Inc. is the leading media brand and playbook for the entrepreneurs and business leaders shaping our future. Through its journalism, Inc. aims to inform, educate, and elevate the profile of its community: the risk-takers, the innovators, and the ultra-driven go-getters who are creating the future of business. Inc. is published by Mansueto Ventures LLC, along with fellow leading business publication Fast Company. For more information, visit www.inc.com.